Biologist - Biomarker Development at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor's and/or Master's degree in Neuroscience, Biology, Biochemistry or related scientific fields with 3+ years industry or academic experience

Responsibilities

Collaborate with project team leads and senior scientists to develop and execute study plans and in vitro experiments
Prepare and organize samples for analysis, including tissue processing and RNA/DNA/protein isolation
Perform assays on samples from preclinical animal models and humans, such as qRT-PCR, immunoassays, and Western blots
Utilize automation to conduct low/medium/high throughput assays
Develop and execute assay validation procedures to deliver high-performance biomarker assays
Process data using statistical analysis and data visualization software for presentations and reports
Accurately document experimental results in an electronic notebook
Perform general laboratory housekeeping tasks, including inventory management, instrument maintenance, and safety inspections
Work independently and as part of a team in a flexible, collaborative environment
Demonstrate excellent written and oral communication skills and the ability to collaborate across functional boundaries
Exhibit strong operational skills, including prioritizing and executing multiple tasks simultaneously
Adapt to changing project needs and timelines

Skills

in vitro biology

biomarker development

qRT-PCR

immunoassays

Western blots

RNA isolation

DNA isolation

protein isolation

tissue processing

assay validation

automation

preclinical models

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free